Page last updated: 2024-11-08

oxytocin, n-acetyl-2-o-methyl-tyr-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

oxytocin, N-acetyl-2-O-methyl-Tyr-: specific antagonist of oxytocin; an oxytocin receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161674
SCHEMBL ID15511260
MeSH IDM0048898

Synonyms (9)

Synonym
oxytocin, n-acetyl-2-o-methyl-tyr-
30750-55-1
oxytocin, n-acetyl-2-o-methyltyrosine-
n-acetyl-2-o-methyltyrosine-oxytocin
n-acetyl-2-o-methyl-tyr-oxytocin
oxytocin, n-acetyl-2-(o-methyl-l-tyrosine)-
einecs 250-326-4
n-acetyl-2-o-methyl-tyrosine-oxytocin
SCHEMBL15511260
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]